Literature DB >> 8200770

Successful pregnancy in I.D.D.M. with intravenous programmable insulin pump.

E Brosnan1, J G Devlin.   

Abstract

Management of subcutaneous insulin resistance remains a difficult problem which can be treated by administering insulin intravenously by means of infusion pumps. We wish to report the case of a 31 year old primigravida with subcutaneous insulin resistance who developed a hitherto undescribed clinical complication of clot formation at the catheter tip, successfully treated with anti-coagulant therapy. Previous publications on the use of pumps in pregnancy have reported on the intraperitoneal route for insulin administration.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8200770     DOI: 10.1007/bf02943015

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  5 in total

1.  Quantitation of free, total, and antibody-bound insulin in insulin-treated diabetics.

Authors:  W D Gennaro; J D Van Norman
Journal:  Clin Chem       Date:  1975-06       Impact factor: 8.327

2.  A simple method for the determination of serum free insulin levels in insulin-treated patients.

Authors:  S Nakagawa; H Nakayama; T Sasaki; K Yoshino; Y Y Yu
Journal:  Diabetes       Date:  1973-08       Impact factor: 9.461

3.  [Treatment of resistance to subcutaneous insulin with implanted insulin infusion pumps].

Authors:  S Löchli; I Campbell; H Dorenboos; K R Paterson; J G Devlin; G Hagmüller; K Irsigler
Journal:  Dtsch Med Wochenschr       Date:  1988-09-09       Impact factor: 0.628

4.  Diabetic pregnancy managed with intraperitoneal insulin.

Authors:  V A Fonseca; R K Menon; P M O'Brien; O N Fernando; R Stephen; P Dandona
Journal:  Diabet Med       Date:  1987 Jan-Feb       Impact factor: 4.359

5.  A preliminary trial of the programmable implantable medication system for insulin delivery.

Authors:  C D Saudek; J L Selam; H A Pitt; K Waxman; M Rubio; N Jeandidier; D Turner; R E Fischell; M A Charles
Journal:  N Engl J Med       Date:  1989-08-31       Impact factor: 91.245

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.